Developing a promising therapy is only one part of bringing a new treatment to market. Biotechnology companies must also navigate...
The friction vs fraud problem In financial services, fraud has become a boogeyman. Attacks are growing. Fraudsters are getting smarter....
Manual reporting remains a pervasive yet underappreciated drag on value creation across many PE-backed companies, potentially slowing decision-making, obscuring risk,...
Somewhere in almost every large company right now, a version of the same meeting is taking place. Two years ago,...
Developing a promising therapy is only one part of bringing a new treatment to market. Biotechnology companies must also navigate...
Read moreDetailsDeveloping a promising therapy is only one part of bringing a new treatment to market. Biotechnology companies must also navigate...
AI must challenge investigative assumptions - not simply accelerate existing thinkingAI could transform criminal investigations by helping investigators navigate large...
The next phase of UK AI policy should reflect how businesses are actually using the technology: alongside human craft, judgement...
Well, this is alarming: “In a regression pitting every variable against each other, AI-identity stance was the single strongest predictor...
Developing a promising therapy is only one part of bringing a new treatment to market. Biotechnology companies must also navigate...
AI must challenge investigative assumptions - not simply accelerate existing thinkingAI could transform criminal investigations by helping investigators navigate large...
© 2025 Silicon Valleys Journal.